Anhydrovinblastine for the treatment of cervical and lung cancer
CA 2219095 A1 · Owner: Schmidt, Bruce · Inventors: Mayer, Lawrence; Kutney, James; Schmidt, Bruce
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention is particularly directed to the use of a derivative of vinblastine 3',4'-anhydrovinblastine (AHVB), which differs from vinblastine in that it possesses a double bond at the 3',4' position of the caranthine nucleus rather than the hydroxyl group that is present in the parent structure, as an anti-neoplastic agent in the therapeutic treatment of cancer.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 24, 1997. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 24, 2017.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 24, 2019.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.